Chaonong Cai

Correction Open access Published: 04 March 2025 BMC Cancer volume 25, Article number: 391 (2025) Cite this article The Original Article was published on 06 December 2023 Correction: BMC Cancer 23, 1198 (2023) Following publication of the original article [1], the authors identified that the image of “Huh7 (Sorafenib) CAFs” group in Figure 2b of this article is wrong, which is the same as the image of “Huh7 (Sorafenib) CAFs + AMD3100” in Figure 3c.

Lukun Yang,1,2,* Ling Li,3,* Peiping Li,1,* Jiafan Chen,1 Chaonong Cai,1 Yingbin Jia,1 Jian Li,1 Baojia Zou1 1Department of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, People’s Republic of China; 2Department of Anesthesiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, People’s Republic of China; 3Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-Sen University,...

Human HCC tissues were obtained in post-surgical samples, from the department of hepatobiliary surgery, at the Fifth Affiliated Hospital of Sun Yat-sen University. All subjects signed an informed consent form, and the study was approved by the Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University. Cancer-associated fibroblasts (CAFs) and paracancerous normal fibroblasts (NFs) were isolated from HCC tissues and non-tumor tissues adjacent to the HCC, respectively.